BIOFIL CHEMICALS & PHARMACEUTICALS LTD.
BSE: 524396
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 12.35+63.2% | 7.57+783.5% | 0.86-93.7% | 13.54+110.5% | 6.43-23.0% | 8.35-41.2% | 14.20+488.3% | 2.41 |
| Other Income | 0.06-42.3% | 0.11+38.6% | 0.08+23.5% | 0.06-97.8% | 2.83+1096.5% | 0.24+929.1% | 0.02+43.7% | 0.02 |
| Total Income | 12.41+61.7% | 7.67+721.1% | 0.93-93.1% | 13.60+46.8% | 9.26+7.9% | 8.59-39.6% | 14.22+485.3% | 2.43 |
| EXPENSES | ||||||||
| Expenditure | 12.28+70.4% | 7.21+770.3% | 0.83-93.9% | 13.49+107.5% | 6.50-22.0% | 8.33-40.5% | 14.00+484.2% | 2.40 |
| Tax | 0.03-90.3% | 0.26+833.1% | 0.03-2.1% | 0.03-92.0% | 0.35+548.5% | 0.05-4.9% | 0.06+612.5% | 0.01 |
| PROFIT | ||||||||
| PBT | 0.13-71.4% | 0.47+339.4% | 0.11-4.5% | 0.11-96.0% | 2.76+988.5% | 0.25+14.3% | 0.22+572.7% | 0.03 |
| Net Profit | 0.11-48.6% | 0.21+167.9% | 0.08-5.3% | 0.08-96.5% | 2.41+1107.9% | 0.20+21.0% | 0.17+587.5% | 0.02 |
| KEY METRICS | ||||||||
| OPM % | 1.14%-4.60pp | 5.74%-5.34pp | 11.08%+10.24pp | 0.84%+0.75pp | 0.09%-1.20pp | 1.29%+0.66pp | 0.63%+4.40pp | -3.77% |
| NPM % | 0.88%-1.89pp | 2.77%-5.70pp | 8.47%+7.86pp | 0.61%-25.41pp | 26.02%+23.70pp | 2.32%+1.16pp | 1.16%+0.17pp | 0.99% |
| EPS | 0.07-46.2% | 0.13+160.0% | 0.05+0.0% | 0.05-96.6% | 1.48+1133.3% | 0.12+20.0% | 0.10+900.0% | 0.01 |
Corporate Events
Board MeetingBIOFILCHEM
202623Sep
Board Meeting
The 41st Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗ Board MeetingBIOFILCHEM
202611Aug
Board Meeting
To consider and approve the Un-Audited Financial Results of …
BSE Filing ↗ Board MeetingBIOFILCHEM
202630May
Board Meeting
To consider and approve the Audited Financial Results of the…
BSE Filing ↗ Board MeetingBIOFILCHEM
202413Aug
Board Meeting
Consider and approve Un-Audited Financial Results of the Com…
BSE Filing ↗ Board MeetingBIOFILCHEM
202430May
Board Meeting
Consider and Approve Audited Financial Results for the fourt…
BSE Filing ↗